8 results on '"Giacomini, Andrea"'
Search Results
2. Minimally invasive or conventional edge-to-edge repair for severe mitral regurgitation due to bileaflet prolapse in Barlow's disease: does the surgical approach have an impact on the long-term results?
- Author
-
De Bonis, Michele, Lapenna, Elisabetta, Del Forno, Benedetto, Di Sanzo, Stefania, Giacomini, Andrea, Schiavi, Davide, Vicentini, Luca, Latib, Azeem, Pozzoli, Alberto, Pappalardo, Federico, La Canna, Giovanni, and Alfieri, Ottavio
- Subjects
MITRAL valve insufficiency ,MITRAL valve prolapse treatment ,INFANTILE scurvy ,THORACOTOMY ,STRESS echocardiography ,THERAPEUTICS - Abstract
OBJECTIVES: To evaluate whether the adoption of a right minithoracotomy operative approach had an impact on the long-term results of edge-to-edge (EE) repair compared to conventional sternotomy in patients with Barlow's disease and bileaflet prolapse. METHODS: We assessed the long-term results of 104 patients with Barlow's disease treated with a minimally invasive EE technique. An equal number of patients had a conventional median sternotomy EE repair for the same disease and were used as a control group. The inverse probability of treatment weighting was used to create comparable distributions of the covariates that were significantly different at baseline in the two groups. We performed a comparative analysis of the groups. RESULTS: No hospital deaths were observed. Follow-up was 99.5% complete (median 11.3 years). The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk, showed no difference between the two groups (P = 0.87). At 12 years, the CIF of recurrent MR>3+, with death as the competing risk, was 7% in the sternotomy group and 5% in the minimally invasive group (P = 0.30), and the CIF of recurrence of MR>2+ was 15 and 14%, respectively (P = 0.63). The type of surgical approach was not a predictor of cardiac death, reoperation, recurrent MR>3+ or recurrent MR>2+. CONCLUSIONS: A minimally invasive approach does not have a negative impact on the effectiveness and long-term durability of the EE repair for bileaflet prolapse in Barlow's disease. Long-term outcomes are excellent, and valvular performance remains stable over time with no evidence of mitral stenosis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Long-term results of mitral repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: does the technique matter?
- Author
-
De Bonis, Michele, Lapenna, Elisabetta, Barili, Fabio, Nisi, Teodora, Calabrese, Mariachiara, Pappalardo, Federico, Canna, Giovanni La, Pozzoli, Alberto, Buzzatti, Nicola, Giacomini, Andrea, Alati, Emanuela, and Alfieri, Ottavio
- Subjects
MITRAL valve insufficiency ,DILATED cardiomyopathy ,CONFIDENCE intervals ,QUALITY of life ,LEFT ventricular hypertrophy - Abstract
OBJECTIVES: An isolated undersized annuloplasty was used to treat mitral regurgitation (MR) secondary to dilated cardiomyopathy (DCM) if the baseline coaptation depth (CD) was <1 cm. In the presence of significant tethering of the mitral leaflets (CD ≥1 cm), the edge-to-edge (EE) technique was combined with annuloplasty to improve the durability of the repair. The long-term results of this approach are unknown and represent the objective of this study. METHODS: To obtain long-term outcome data, we included in the study population the first 105 consecutive patients with severe left ventricular dysfunction (ejection fraction 29 ± 6.6%) and secondaryMR submitted tomitral valve repair. Forty patients underwent isolated undersized annuloplasty and 65 patients received the EE technique combined with annuloplasty. Preoperative and postoperative data were prospectively entered into a dedicated database. Clinical and echocardiographic follow-ups were performed in our institutional outpatient clinic. RESULTS: Follow-up was 90% complete. The median follow-up time was 7.2 years (interquartile range 4.3;10.4). The longest follow-up time was 16.5 years. A comparative analysis between the annuloplasty group and the EE group was performed. Baseline LV dimensions and function were slightly worse in the EE group, but only the severity of tethering was significantly more pronounced than in the annuloplasty group. Hospital mortality (3 vs 2.5%, P = 1.0) and 10-year overall survival (42 ± 6.7 vs 55 ± 8.5%, P = 0.2) were not significantly different in the EE and annuloplasty group, respectively. Cumulative incidence functions of cardiac death were similar as well (at 10-years, 34.3 ± 8.1 vs 37.9 ± 6.4%, respectively, P = 0.4). At 10 years, cumulative incidence function of recurrence of MR ≥3+ was lower in the EE patients (10.3 ± 4.1 vs 30.8±8.0%, P = 0.01). Isolated annuloplasty [hazard ratio (HR) 4.84, 95% confidence interval (CI) 1.46-16.1, P = 0.01] and residual MR >1+ at hospital discharge (HR 5.25, 95% CI 2.00-13.8, P < 0.001) were significantly related to the development of MR ≥3. Failure of repair was associated with recurrence of New York Heart Association III or IV symptoms (P < 0.001). CONCLUSIONS: In patients with end-stage DCM and secondary MR, the association of the EE technique to the undersized annuloplasty significantly decreases the rate of recurrent MR at long-term. This higher repair durability did not translate into a better long-term prognosis in this series. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: mid-term results of a single-centre experience.
- Author
-
De Bonis, Michele, Taramasso, Maurizio, Lapenna, Elisabetta, Denti, Paolo, La Canna, Giovanni, Buzzatti, Nicola, Pappalardo, Federico, Di Giannuario, Giovanna, Cioni, Micaela, Giacomini, Andrea, and Alfieri, Ottavio
- Subjects
MITRAL valve insufficiency ,LEFT heart ventricle ,PULMONARY artery ,REGULATION of heart contraction ,CARDIAC surgery - Abstract
OBJECTIVES: To compare the surgical and percutaneous edge-to-edge (EE) repair in patients with severe left ventricular (LV) dysfunction and secondary mitral regurgitation (MR). METHODS: We reviewed the prospectively collected data of the first 120 consecutive patients (age: 65 ± 9.8 years, EF: 28 ± 8.2%) treated with surgical (65 patients) or percutaneous (55 patients) EE repair for severe secondary MR in our institution. Age (P = 0.005) and logistic European System for Cardiac Operative Risk Evaluation (P < 0.0001) were significantly higher in the MitraClip group. LVEF (P = 0.37), end-diastolic (P = 0.83) and end-systolic (P = 0.68) volumes and systolic pulmonary artery pressure (SPAP) (P = 0.58) were similar. The follow-up was 100% complete [median: 4 years; interquartile range (IQR): 2.2-7.2]. RESULTS: The length of hospital stay was 10 days (IQR: 8-13) for surgery and 5 days (IQR: 3.9-7.8) for MitraClip (P < 0.0001). Hospital mortality (3 vs 0%, P = 0.49) and freedom from cardiac death at 4 years (80.8 ± 4.9% vs 79.1 ± 5.9%, P = 0.9) were not significantly different in the surgical and MitraClip group, respectively. Residual MR ≥ 2+ at hospital discharge was 7.6% for surgery and 29% for MitraClip (P = 0.002). At 4 years, freedom from MR ≥ 2+ (74.9 ± 5.6% vs 51.4 ± 7.4%, P = 0.01) and freedom from MR≥ 3+ (92.8 ± 3.4% vs 68.1 ± 7%, P = 0.002) were both significantly higher in the surgical group. Multivariate analysis identified the use of MitraClip as an independent predictor of recurrence of MR ≥ 2+ [Hazard ratio (HR): 2.1, 95% confidence interval (CI): 1.1-3.9, P = 0.02] as well as of MR≥ 3 (HR: 6.1, 95% CI: 1.5-24.3, P = 0.01). In the surgical group, no predictors of cardiac mortality were identified. In the MitraClip group, left ventricular end-diastolic diameter (HR: 1.1, 95% CI: 1-1.2, P = 0.005) and SPAP (HR: 1, 95% CI: 1-1.1, P = 0.005) were independent predictors of cardiac death at the follow-up. CONCLUSIONS: MitraClip therapy is a safe therapeutic option in selected high-risk patients with secondary MR and relevant comorbidities. The surgical EE provides higher efficacy both postoperatively and at the mid-term follow-up. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. Excellent long-term results with minimally invasive edge-to-edge repair in myxomatous degenerative mitral valve regurgitation
- Author
-
Stefania Ruggeri, Michele De Bonis, Andrea Giacomini, Ottavio Alfieri, Igor Belluschi, Elisabetta Lapenna, Davide Schiavi, Alessandro Castiglioni, Benedetto Del Forno, Andrea Blasio, Belluschi, Igor, Lapenna, Elisabetta, Blasio, Andrea, Del Forno, Benedetto, Giacomini, Andrea, Ruggeri, Stefania, Schiavi, Davide, Castiglioni, Alessandro, Alfieri, Ottavio, and De Bonis, Michele
- Subjects
Adult ,Male ,Reoperation ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Time Factors ,Minithoracotomy ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Myxomatous degeneration ,Ventricular Function, Left ,03 medical and health sciences ,0302 clinical medicine ,Recurrence ,Interquartile range ,Mitral valve ,medicine ,Humans ,Cumulative incidence ,Cardiac Surgical Procedures ,Minimally invasive ,Mitral valve repair ,Mitral regurgitation ,Ejection fraction ,business.industry ,Mitral Valve Insufficiency ,Stroke Volume ,medicine.disease ,Surgery ,Survival Rate ,Treatment Outcome ,medicine.anatomical_structure ,Italy ,Thoracotomy ,030228 respiratory system ,Mitral Valve ,Female ,Cardiology and Cardiovascular Medicine ,Mitral valve regurgitation ,business ,Follow-Up Studies - Abstract
OBJECTIVES Previous series of minimally invasive mitral valve repairs showed excellent results at up to 10 years of follow-up. The goal of this study was to assess the long-term durability beyond 10 years of the edge-to-edge repair for myxomatous degeneration performed through a minimally invasive approach. METHODS Ninety-seven consecutive patients (mean age 35 ± 9 years; left ventricular ejection fraction 63 ± 6%) with severe myxomatous mitral regurgitation (MR) underwent mitral valve repair through a right minithoracotomy between 1999 and 2006. MR was due to lesions involving the posterior leaflet (7.2% of patients), anterior leaflet (12.4%) and both leaflets (80.4%). RESULTS No hospital deaths occurred. At hospital discharge all patients had no or trivial MR. Follow-up was 100% complete (median 15.5 years; interquartile range 13.6–17.0, max 19.3 years). The 16-year overall survival rate was 95.9 ± 2.02% [95% confidence interval (CI) 89.39–98.43]. At 16 years, the cumulative incidence function of cardiac death, with non-cardiac death as a competing risk, was 3.1 ± 1.75 (95% CI 0.83–8.02). Only 3 patients (4.1%) had redo operations for recurrent severe MR. At 16 years, the cumulative incidence functions of reoperation for and recurrence of MR ≥3+, with death as a competing risk, were 3.1 ± 1.76% (95% CI 0.83–8.02) and 5.6 ± 2.47% (95% CI 2.06–11.83), respectively. No predictors of recurrence of MR ≥3+ were identified. At the last follow-up, moderate MR (2+/4+) was detected in 17 patients (17.5%); most of the patients were in New York Heart Association functional class I–II (97%) and in sinus rhythm (90%). CONCLUSIONS Minimally invasive mitral valve edge-to-edge repair through a right minithoracotomy for myxomatous degeneration appears to be an effective and durable approach even in the long-term follow-up (up to 19 years).
- Published
- 2020
- Full Text
- View/download PDF
6. Minimally invasive or conventional edge-to-edge repair for severe mitral regurgitation due to bileaflet prolapse in Barlow’s disease: does the surgical approach have an impact on the long-term results?†
- Author
-
Alberto Pozzoli, Davide Schiavi, Federico Pappalardo, Elisabetta Lapenna, Giovanni La Canna, Stefania Di Sanzo, Azeem Latib, Benedetto Del Forno, Andrea Giacomini, Michele De Bonis, Ottavio Alfieri, Luca Vicentini, University of Zurich, De Bonis, Michele, DE BONIS, Michele, Lapenna, Elisabetta, Del Forno, Benedetto, Di Sanzo, Stefania, Giacomini, Andrea, Schiavi, Davide, Vicentini, Luca, Latib, Azeem, Pozzoli, Alberto, Pappalardo, Federico, Canna, Giovanni La, and Alfieri, Ottavio
- Subjects
Male ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,0302 clinical medicine ,Mitral valve ,Mitral valve prolapse ,Mitral Valve Prolapse ,Barlow’s disease ,General Medicine ,Middle Aged ,2746 Surgery ,Survival Rate ,Treatment Outcome ,medicine.anatomical_structure ,Italy ,Thoracotomy ,Cardiology ,Mitral Valve ,Female ,Barlow's disease ,Cardiology and Cardiovascular Medicine ,Adult ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,610 Medicine & health ,2705 Cardiology and Cardiovascular Medicine ,03 medical and health sciences ,Mitral valve stenosis ,Internal medicine ,medicine ,Humans ,Minimally Invasive Surgical Procedures ,Minimally invasive ,Survival rate ,Retrospective Studies ,Mitral regurgitation ,Mitral valve repair ,business.industry ,medicine.disease ,10020 Clinic for Cardiac Surgery ,Surgery ,Stenosis ,030228 respiratory system ,2740 Pulmonary and Respiratory Medicine ,Median sternotomy ,Right minithoracotomy ,business ,Echocardiography, Transesophageal ,Follow-Up Studies ,Forecasting - Abstract
Objectives To evaluate whether the adoption of a right minithoracotomy operative approach had an impact on the long-term results of edge-to-edge (EE) repair compared to conventional sternotomy in patients with Barlow's disease and bileaflet prolapse. Methods We assessed the long-term results of 104 patients with Barlow's disease treated with a minimally invasive EE technique. An equal number of patients had a conventional median sternotomy EE repair for the same disease and were used as a control group. The inverse probability of treatment weighting was used to create comparable distributions of the covariates that were significantly different at baseline in the two groups. We performed a comparative analysis of the groups. Results No hospital deaths were observed. Follow-up was 99.5% complete (median 11.3 years). The cumulative incidence function (CIF) of cardiac death at 12 years, with noncardiac death as a competing risk, showed no difference between the two groups ( P = 0.87). At 12 years, the CIF of recurrent MR ≥ 3+, with death as the competing risk, was 7% in the sternotomy group and 5% in the minimally invasive group ( P = 0.30), and the CIF of recurrence of MR ≥ 2+ was 15 and 14%, respectively ( P = 0.63). The type of surgical approach was not a predictor of cardiac death, reoperation, recurrent MR ≥ 3+ or recurrent MR ≥ 2+. Conclusions A minimally invasive approach does not have a negative impact on the effectiveness and long-term durability of the EE repair for bileaflet prolapse in Barlow's disease. Long-term outcomes are excellent, and valvular performance remains stable over time with no evidence of mitral stenosis.
- Published
- 2017
- Full Text
- View/download PDF
7. Second cross-clamping after mitral valve repair for degenerative disease in contemporary practice
- Author
-
Roberta Meneghin, Michele De Bonis, Ottavio Alfieri, Elisabetta Lapenna, Federico Pappalardo, Marcello Raimondi Lucchetti, Alessandro Castiglioni, Ilaria Giambuzzi, Andrea Giacomini, Nicola Buzzatti, Cinzia Trumello, Giovanni Affronti, De Bonis, Michele, Lapenna, Elisabetta, Giambuzzi, Ilaria, Meneghin, Roberta, Affronti, Giovanni, Pappalardo, Federico, Castiglioni, Alessandro, Trumello, Cinzia, Buzzatti, Nicola, Giacomini, Andrea, Raimondi Lucchetti, Marcello, and Alfieri, Ottavio
- Subjects
Pulmonary and Respiratory Medicine ,Male ,Reoperation ,medicine.medical_specialty ,medicine.medical_treatment ,Cardiopulmonary bypa ,030204 cardiovascular system & hematology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Interquartile range ,law ,Recurrence ,medicine ,Cardiopulmonary bypass ,Humans ,Systole ,Mitral regurgitation ,Aged ,Retrospective Studies ,Second cross-clamping ,Mitral valve repair ,Cardiopulmonary Bypass ,business.industry ,Incidence (epidemiology) ,Mitral Valve Insufficiency ,Retrospective cohort study ,General Medicine ,Middle Aged ,Constriction ,Confidence interval ,Surgery ,030228 respiratory system ,Second pump run ,Mitral Valve ,Female ,Cardiology and Cardiovascular Medicine ,business ,Echocardiography, Transesophageal ,Follow-Up Studies - Abstract
Objectives Scanty data are available on 'second cross-clamping' following mitral valve repair in contemporary practice. The aim of this study was to evaluate the incidence, causes and outcomes of this event in patients referred for mitral repair for severe degenerative mitral regurgitation (MR). Methods The study population included 2318 patients with severe degenerative MR referred for mitral repair. A second cross-clamping was performed in 94 (4%) patients. Causes of the second cross-clamping, revising repair procedures, immediate echocardiographic outcomes and postoperative course were assessed and compared with the 'single cross-clamping cases' (2224 patients used as control). Clinical and echocardiographic follow-up information was available for 91 of the 94 second cross-clamping patients (97% complete) (median time 6 years, interquartile range 3-11). Results The most frequent causes of the second cross-clamping were residual MR >1+/4+ and systolic anterior motion. A residual prolapse was identified in 41 (43.5%) patients, systolic anterior motion in 22 (23.5%), untreated clefts in 14 (15%) and other mechanisms in 17 (18%). Second cardiopulmonary bypass and aortic cross-clamping times were 36 (range 28-50) and 23 (range 17-34) min, respectively. Hospital mortality was 0% in the second cross-clamping and 0.3% in the control group (P = 0.2). Postoperative complications and length of hospital stay were similar. At discharge, residual MR ≥2+/4+ was 2.1% in the second cross-clamping and 2.7% in the control group (P = 0.99). In the second cross-clamping, at 12 years, the cumulative incidence function of reoperation, recurrent MR ≥3+ and MR ≥2+ with death as competing risk were 5.7 ± 2.5% (95% confidence interval 2-12), 10.3 ± 4.3% (95% confidence interval 3.8-20) and 17 ± 5.2% (95% confidence interval 8-29), respectively. Conclusions In a large volume centre for mitral repair, a second cross-clamping is still performed in 3-5% of the patients. Because suboptimal immediate results are associated with impaired late outcomes of mitral reconstruction, a low threshold for a second cross-clamping seems to be justified. If the second repair is carried out with a relatively shorter additional cross-clamping time, mortality and morbidity are not increased and immediate and long-term results are very satisfactory.
- Published
- 2017
8. Mitral valve annuloplasty
- Author
-
Michele De Bonis, Ottavio Alfieri, Alessandra Sala, Andrea Giacomini, Alessandro Castiglioni, Benedetto Del Forno, Alberto Geretto, Paolo Denti, Del Forno, Benedetto, Castiglioni, Alessandro, Sala, Alessandra, Geretto, Alberto, Giacomini, Andrea, Denti, Paolo, De Bonis, Michele, and Alfieri, Ottavio
- Subjects
Mitral valve repair ,medicine.medical_specialty ,Mitral Valve Annuloplasty ,business.industry ,medicine.medical_treatment ,Ring annuloplasty ,Surgical risk ,Surgery ,Heart Valve Disease ,medicine.anatomical_structure ,Mitral valve annuloplasty ,Mitral valve ,cardiovascular system ,medicine ,Mitral Valve ,cardiovascular diseases ,business ,Reduction (orthopedic surgery) ,Mitral valve surgery ,Human - Abstract
Mitral valve prosthetic ring annuloplasty represents a key milestone in the history of mitral valve repair, delivering restoration of annular shape and size. Increased leaflet coaptation, together with significant reduction in stress on sutures, has ensured predictability and immediate stability for valve repair, both of which were lacking with previous techniques. Long-term durability of repair seems to be positively affected by placement of an annuloplasty ring, and by following the well-established, standardized approach described in our tutorial, this procedure can be performed with a very low surgical risk.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.